Staining patterns are evaluated based on consistency between staining patterns
of multiple antibodies against the same target and match to transcriptomics data.
Not exact matches
Earlier this month, the FDA approved two other treatments for
multiple myeloma, including another kind
of monoclonal
antibody drug (the same class
of drug that elotuzumab is in).
Breech Twins and higher order
multiples Previous CS Pre-Eclampsia Placenta praevia Cervical incompetence Previous late stillbirth Previous premature birth Grand multiparty Age under 18 Age over 35 Smoking Drug use Severe mental health issue Epilepsy Type 1 diabetes Type 2 diabetes Gestational diabetes Asthma GBS positive Abnormal
antibodies Transplant recipient Congenital heart disease Known foetal abnormality Immunosuppressive medication MS Physical disability Intellectual disability Hypothyroidism Hyperthyroidism Previous shoulder dystocia Previous 3rd or 4th degree tear Sickle Cell anaemia BMI under 18 or over 35 at conception Previous massive PPH APH in current pregnancy HIV / AIDS Hepatitis B or C Active TB IUGR Oligohydramnios Polyhydramnios Child previously removed from custody because
of abuse Uterine abnormalities such as uterine septum or double uterus Previous uterine surgery for fibroids Chronic renal problems Hypertension Auto immune condition Previous stroke or blod clot Cancer Domestic violence or abusive home Prisoners Homeless women
(borrowed from Dr Kitty) Breech Twins and higher order
multiples Previous CS Pre-Eclampsia Placenta praevia Cervical incompetence Previous late stillbirth Previous premature birth Grand multiparty Age under 18 Age over 35 Smoking Drug use Severe mental health issue Epilepsy Type 1 diabetes Type 2 diabetes Gestational diabetes Asthma GBS positive Abnormal
antibodies Transplant recipient Congenital heart disease Known foetal abnormality Immunosuppressive medication MS Physical disability Intellectual disability Hypothyroidism Hyperthyroidism Previous shoulder dystocia Previous 3rd or 4th degree tear Sickle Cell anaemia BMI under 18 or over 35 at conception Previous massive PPH APH in current pregnancy HIV / AIDS Hepatitis B or C Active TB IUGR Oligohydramnios Polyhydramnios Child previously removed from custody because
of abuse Uterine abnormalities such as uterine septum or double uterus Previous uterine surgery for fibroids Chronic renal problems Hypertension Auto immune condition Previous stroke or blod clot Cancer Domestic violence or abusive home Prisoners Homeless women
«In the case
of multiple sclerosis, as a patient progresses through steps
of the disease, their body generates novel
antibodies or higher existing
antibody titers against certain proteins, such as myelination proteins.
Our data demonstrate the feasibility
of targeted gene disruption in
multiple rat strains within 4 months time, paving the way to a humanized monoclonal
antibody platform and additional human disease models.
Two
of the
antibodies in the MB - 003 cocktail target a related region
of the Ebola virus glycoprotein, and thus are more susceptible to localized changes affecting
multiple antibodies.
The most likely theory, they say, is that
multiple tetanus toxoid vaccines may produce
antibodies that respond to the combination
of the capsular pathogen and its carrier.
Multiple myeloma is preceded by a blood disorder called monoclonal gammopathy
of undetermined significance (MGUS) in which abnormal plasma cells produce many copies
of an
antibody protein.
The discovery
of how a KwaZulu - Natal woman's body responded to her HIV infection by making potent
antibodies (called broadly neutralizing
antibodies, because they are able to kill
multiple strains
of HIV from across the world), was reported today by the CAPRISA consortium
of AIDS researchers jointly with scientists from the United States.
A randomized phase III trial finding that a new monoclonal
antibody, elotuzumab, added to standard therapy, extended the duration
of remission for patients with relapsed
multiple myeloma by about five months Findings from two phase III studies showing that children with Wilms tumor who have a specific chromosomal abnormality do better with a more intensive, augmented chemotherapy regimen
Current estimates are that only about five percent
of AIDS patients can produce these potent
antibodies to HIV, and only
multiple years after infection.
Using
multiple statistical approaches to study a long - term pediatric cohort in Nicaragua, we show that risk
of severe dengue disease is highest within a narrow range
of preexisting anti-DENV
antibody titers.
In its first clinical trial, a breakthrough
antibody therapy produced at least partial remissions in a third
of patients with
multiple myeloma who had exhausted
multiple prior treatments, investigators at Dana - Farber Cancer Institute and other organizations report today online in the New England Journal
of Medicine.
This «suggests that
antibodies specific for this conserved region could provide protection against
multiple toxin - mediated clostridium infections and points to a generalizable strategy for generating safe vaccine antigens for this class
of toxins,» they concluded.
Brilliant Violet dye conjugated secondary
antibodies from Jackson ImmunoResearch allow the addition
of more colors to
multiple labeling assays.
BV421 and BV480 are available conjugated to a range
of secondary
antibodies recommended for
multiple labeling due to their minimal cross-reactivity.
«The quality
of these naturally occurring human
antibodies as biological drugs to treat the virus infection is remarkable, and we are doubly encouraged because they recognize
multiple species
of Ebola,» said immunologist James Crowe, Director
of the Vanderbilt Vaccine Center.
In addition to neutralizing
multiple Ebolavirus species, one
of the
antibodies also protected guinea pigs from a lethal challenge
of virus.
The
antibodies were then used to investigate whether rogue proteins existed in the brain tissue and spinal fluid
of patients with
multiple sclerosis.
Such vaccines, which would contain
multiple AMA1 sequences in complex with RON2, might induce
antibodies targeted to a range
of genetically diverse malaria parasites.
The development
of trispecific multivalent
antibodies combine the best attributes
of each into a single molecule capable
of recognizing and neutralizing
multiple viruses not recognized by the individual bnAbs.
The 5E5
antibody recognized
multiple types
of cancer cells, including leukemia, ovarian, breast, and pancreatic cancer cells, but not normal tissues.
A separate group
of mice that also received CD8 T cells or
antibodies specific to the virus were protected from this detrimental outcome, indicating the importance
of inducing
multiple arms
of the immune response.
Scientists looking at the antiviral mechanisms
of two previously identified human monoclonal
antibodies have found they potently inhibit chikungunya virus (CHIKV) at
multiple stages
of infection.
Furthermore, these
antibodies prevent CHIKV from both entering and exiting cells, whereas prior studies
of neutralizing
antibodies to CHIKV and
multiple other classes
of viruses have focused on the capacity to block viruses from entering a cell.
«An obstacle to creating an effective HIV vaccine is the difficulty
of getting the immune system to generate
antibodies against the sugar shield
of multiple HIV strains,» said Lai - Xi Wang, a professor
of chemistry and biochemistry at UMD.
But this week, researchers report that they've nabbed
antibodies that disable
multiple varieties
of the virus.
More proof came when the researchers inhibited Udx1 with
antibodies or drugs: the egg's membrane did not harden after fertilization, and
multiple sperm entered, the team reports in this month's issue
of Developmental Cell.
Unlike
antibodies elicited by annual influenza vaccinations, most neutralizing
antibodies induced by pandemic H1N1 infection were broadly cross-reactive against epitopes in the hemagglutinin (HA) stalk and head domain
of multiple influenza strains.
They discovered that attachment is probably mediated by
multiple weak interactions, which could potentially be blocked by a combination
of drugs or
antibodies.
We also demonstrate that
multiple broadly neutralizing
antibody lineages can be raised against HIV in the llama HCAb model and that, when combined as purified VHH, they provide enhanced breadth and potency
of neutralization.
«As eliciting a highly diverse immune response may be favorable to providing protection against incredibly diverse HIV - 1 variants in global circulation,» the researchers conclude that their study «supports further investigations
of the molecular and functional characteristics
of the virus -
antibody interplay in superinfected individuals, as superinfection may provide insight to the development
of a diverse Nab response with
multiple epitope specificities.»
Furthermore, there is very limited similarity to the human germ line V gene VH1 - 2 * 02 precursor
of the VRC01 - like broadly neutralizing
antibodies isolated from
multiple patients.
Some
of the anti-influenza
antibodies generated by the technique recognized
multiple strains
of the virus and were able to neutralize its ability to infect cells.
A study led by St. Jude Children's Research Hospital identifies new path to a universal influenza vaccine emphasizing production
of broadly specific
antibodies that target
multiple flu viruses
This is in contrast to the well - characterized VRC01 - like family
of CD4 - binding site
antibodies identified in
multiple HIV - positive donors, which share both a heavy chain V gene precursor and unusual features at a DNA sequence level which could allow sequencing - based identification
of other similar
antibodies in distinct patients [53].
Researchers at Vanderbilt University Medical Center and the University
of Texas Medical Branch in Galveston (UTMB) reported this week in the journal Cell that they have isolated human monoclonal
antibodies from Ebola survivors that can neutralize
multiple species
of the virus.
These findings highlight the need to (a) induce
multiple neutralizing
antibody lineages for a protective
antibody - based vaccine and (b) the potential need to use combinations
of purified mAb in therapeutic or prophylactic settings.
Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model
of Neurodegeneration in
Multiple Sclerosis.
«Over the last 50 years, advances in
antibody technology have delivered radical new treatments for a wide range
of common diseases including rheumatoid arthritis,
multiple sclerosis and some forms
of cancer.
Dr. Polonis» lab has focused for many years on functional
antibodies elicited by natural infection and by vaccination, utilizing samples from
multiple natural history cohorts and vaccine studies; her lab is currently performing an extensive analysis
of pseudovirus neutralizing
antibodies in the large RV144 follow - on trial, RV306.
Cancers
of the breast, prostate, colorectal system, liver and kidney as well as
multiple myeloma, a cancer
of the plasma cells that make
antibodies to fight viruses and bacteria, strike earlier, deadlier and more often in some racial and ethnic groups, the National Cancer Institute has shown.
The investigators found that the immunized monkeys mounted
antibody responses against diverse strains
of HIV and the monkeys also mounted cellular immune responses to
multiple regions
of the virus.
iTeos and Adimab LLC are collaborating on the discovery, development and commercialization
of multiple,
antibody - based therapeutic programs, with Adimab using its
antibody discovery and optimization platform to identify fully human therapeutic
antibodies against targets selected by iTeos.
One theory is, because cows have
multiple stomachs with lots
of bacteria, they need extra-powerful
antibodies to protect them from infection.
Myeloma — also referred to as
multiple myeloma or plasma cell myeloma — is a cancer that originates in plasma cells, a type
of white blood cell that makes
antibodies.
Co-transfection
of 293T cells with NL4 - 3 env plasmid yields an HIV - 1 pseudotype virus that is R5 - tropic and susceptible to neutralization by
multiple antibodies.
As the number
of multiple myeloma cells increases, more
antibodies are made.
One secondary outcome will be immunogenicity, meaning monitoring subjects for any emergence
of antibodies against the infused therapeutic
antibodies themselves; additionally, «
Multiple clinical and exploratory biomarkers will be assessed» in the Phase Ib trial.